Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Establishment for Superior Treatment of PTSD

NCT03343028 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03343028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03343028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Establishment for Superior Treatment of PTSD
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
September 30, 2019
Enrollment
292 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd